Helicobacter and gastric malignancies

Helicobacter

Volumn 13, Issue SUPPL.1, 2008, Pages 28-34

  Ferreira, António Carlos ^a,b   Isomoto, Hajime ^c   Moriyama, Masatsugu ^d   Fujioka, Toshio ^e   Machado, José Carlos ^a,b   Yamaoka, Yoshio ^f  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c NAGASAKI UNIVERSITY   (Japan)

^d OITA UNIVERSITY   (Japan)

^e OITA UNIVERSITY   (Japan)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Gastric cancer; Helicobacter pylori; MALT lymphoma

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CAGA PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CARCINOGENESIS; CELL TRANSFORMATION; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; ERADICATION THERAPY; GENE TRANSLOCATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; STOMACH LYMPHOMA; STOMACH MUCOSA;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 49249090840     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2008.00633.x     Document Type: Article

References (51)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2002 55 : 74 108.
2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984 1 : 1311 5.
3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Carcinog Risks Hum 1994 61 : 1 241.
4. Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, Russi M, Quaranta S. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989 27 : 225 6.
5. Atherton JC, Cao P, Peek M, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995 270 : 17771 7.
6. Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, Quint WG, Carneiro F. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001 36 : 128 35.
7. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Hosseini ME, Atherton JC. A new Helicobacter pylori vacuolating cytotoxin determinant, the Intermediate region, is associated with gastric cancer. Gastroenterology 2007 133 : 926 36.
8. Talley NJ, Fock KM, Moayyedi P. Gastric cancer consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008 103 : 510 4.
9. Kawazoe T, Sakagami T, Nakajima K, Hori K, Fukuda Y, Matsumoto T, Miwa H. Role of bacterial strain diversity of Helicobacter pylori in gastric carcinogenesis induced by N-methyl-N-nitrosourea in Mongolian gerbils. Helicobacter 2007 12 : 213 23.
10. Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci USA 2008 105 : 4358 63.
11. Snider JL, Allison C, Bellaire B, Ferrero RL, Cardelli JA. The β1-integrin activates JNK independent of CagA, and JNK activation is required for Helicobacter pylori CagA+ induced motility of gastric cancer cells. J Biol Chem 2008 283 : 13952 63.
12. Minohara Y, Boyd DK, Hawkins HK, Ernst PB, Patel J, Crowe SE. The effect of the cag pathogenicity island on binding of Helicobacter pylori to gastric epithelial cells and the subsequent induction of apoptosis. Helicobacter 2007 12 : 583 90.
13. Zhang H, Chang DC, Lan CH, Luo YH. Helicobacter pylori infection induces apoptosis in gastric cancer cells through the mitochondrial pathway. J Gastroenterol Hepatol 2007 22 : 1051 6.
14. Murata-Kamiya N, Kurashima Y, Teishikata Y, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007 26 : 4617 26.
15. Kurashima Y, Murata-Kamiya N, Kikuchi K, Higashi H, Azuma T, Kondo S, Hatakeyama M. Deregulation of β-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int J Cancer 2008 122 : 823 31.
16. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res 2003 92 : 827 39.
17. Pillinger MA, Marjanovic N, Kim SY, et al. Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and - independent ERK activation. J Biol Chem 2007 282 : 18722 31.
18. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988 241 : 708 12.
19. Tarnawski AS, Jones MK. The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing. involvement of EGF-R signal transducion pathways. J Clin Gastroenterol 1998 27 : S12 20.
20. Ashktorab H, Daremipouran M, Wilson M, Siddiqi S, Lee EL, Rakhshani N, Malekzadeh R, Johnson AC, Hewitt SM, Smoot DT. Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am J Gastroenterol 2007 102 : 2135 46.
21. Jackson CB, Judd LM, Menheniott TR, Kronborg I, Dow C, Yeomans ND, Boussioutas A, Robb L, Giraud AS. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol 2007 213 : 140 51.
22. Shiotani A, Iishi H, Uedo N, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Hinoi T, Merchant JL. Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression. Aliment Pharmacol Ther 2006 24 : 71 80.
23. Shiotani A, Uedo N, Iishi H, Tatsuta M, Ishiguro S, Nakae Y, Kamada T, Haruma K, Merchant JL. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia. Int J Cancer 2007 121 : 1182 9.
24. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003 349 : 2042 54.
25. Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H. CpG island hypermethylation of tumour-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter 2008 13 : 35 41.
26. Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, Pilotto A, Annese V, Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol 2007 102 : 1361 71.
27. Chan AOO, Chu KM, Huang C, et al. Association between Helicobacter pylori infection and interleukin 1β polymorphism predispose to CpG island methylation in gastric cancer. Gut 2007 56 : 595 7.
28. Qian X, Huang C, Cho CH, Hui WM, Rashid A, Chan AOO. E-cadherin promoter hypermethylation induced by interleukin-1β treatment or H. pylori infection in human gastric cancer cell lines. Cancer Lett 2008 263 : 107 13.
29. Miyazaki T, Murayama Y, Shinomura Y, Yamamoto T, Watabe K, Tsutsui S, Kiyohara T, Tamura S, Hayashi N. E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis. Helicobacter 2007 12 : 523 31.
30. Wang SK, Zhu HF, He BS, Zhang ZY, Chen ZT, Wang ZZ, Wu GL. CagA+ H pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis. World J Gastroenterol 2007 13 : 2923 31.
31. Lundin BS, Enarsson K, Kindlund B, Lundgren A, Johnsson E, Quinding-Jarbrink M, Svennerholm AM. The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterized by production of interleukin-10. Clin Immunol 2007 125 : 205 13.
32. Inagaki H. Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance. Pathol Int 2007 57 : 474 84.
33. Morgner A, Schmelz R, Thiede C, Stolte M, Miehlke S. Therapy of gastric mucosa associated lymphoid tissue lymphoma. World J Gastroenterol 2007 13 : 3554 66.
34. Terai S, Iijima K, Kato K, et al. Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy. Tohoku J Exp Med 2008 214 : 79 87.
35. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 2007 56 : 1685 7.
36. Seo DB, Kwon KS, Park HS, et al. Metachronous gastric MALT lymphoma and early gastric cancer: a case report. Korean J Gastroenterol 2007 49 : 245 50.
37. Isaka T, Nakamura T, Tajika M, et al. API2-MALT1 chimeric transcript-positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7 years. Histopathology 2007 51 : 119 23.
38. Kuo SH, Chen LT, Wu MS, et al. Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: need for a revisit of surgical treatment. Ann Surg 2008 247 : 265 9.
39. Nakamura S, Ye H, Bacon CM, et al. Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation. Gut 2007 56 : 1358 63.
40. Du MQ. MALT lymphoma: recent advances in aetiology and molecular genetics. J Clin Exp Hematop 2007 47 : 31 42.
41. Fukuhara N, Nakamura T, Nakagawa M, et al. Chromosomal imbalances are associated with outcome of Helicobacter pylori eradication in t(11;18)(q21;q21) negative gastric mucosa-associated lymphoid tissue lymphomas. Genes Chromosomes Cancer 2007 46 : 784 90.
42. Nakamura T, Seto M, Tajika M, et al. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Am J Gastroenterol 2008 103 : 62 70.
43. Sakuma H, Nakamura T, Uemura N, et al. Immunoglobulin VH gene analysis in gastric MALT lymphomas. Mod Pathol 2007 20 : 460 6.
44. Nakamura S, Ye H, Bacon CM, Liu H, Goatly A, Matsumoto T, et al. Gastric MALT lymphoma with t(14 ; 18) (q32;q21) involving IGH and BCL2 genes that responded to Helicobacter pylori eradication. J Clin Pathol 2007 60 : 1171 3.
45. Bernasconi B, Karamitopolou-Diamantiis E, Tornillo L, et al. Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approach. Hum Pathol 2008 39 : 536 42.
46. Adam P, Schmausser B, Gobeler-Kolve M, Muller-Hermelink HK, Eck M. Gastric extranodal marginal zone B-cell lymphomas of MALT type exclusively express Toll-like receptor 4 in contrast to other lymphomas infiltrating the stomach. Ann Oncol 2008 19 : 566 9.
47. Venizelos I, Tamiolakis D, Bolioti S, Nikolaidou S. Primary MALT lymphomas of the stomach: a pathological study of 18 cases. Rev Esp Enferm Dig 2007 99 : 270 4.
48. Achyut BR, Moorchung N, Srivastava AN, Gupta NK, Mittal B. Risk of lymphoid follicle development in patients with chronic antral gastritis: role of endoscopic features, histopathological parameters, CagA status and interleukin-1 gene polymorphisms. Inflamm Res 2008 57 : 51 6.
49. De Luca A, De Falco M, Manente L, et al. Helicobacter pylori heat shock protein B (HspB) localizes in vivo in the gastric mucosa and MALT lymphoma. J Cell Physiol 2008 216 : 78 82.
50. Nishikawa K, Nakamura M, Takahashi S, et al. Increased apoptosis and angiogenesis in gastric low-grade mucosa-associated lymphoid tissue-type lymphoma by Helicobacter heilmannii infection in C57/BL6 mice. FEMS Immunol Med Microbiol 2007 50 : 268 72.
51. Ohnishi N, Yuasa H, Tanaka S, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A 2008 105 : 1003 8.